BINDING OF NEU DIFFERENTIATION FACTOR WITH THE EXTRACELLULAR DOMAIN OF HER2 AND HER3

被引:64
|
作者
HORAN, T
WEN, J
ARAKAWA, T
LIU, NL
BRANKOW, D
HU, S
RATZKIN, B
PHILO, JS
机构
[1] Amgen Inc., Amgen Center, Thousand Oaks
关键词
D O I
10.1074/jbc.270.41.24604
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of neu differentiation factor (NDF) with the extracellular domains of Her2 (sHer2) and Her3 (sHer3) have been studied using native gels, light scattering, and sedimentation equilibrium. The full-length NDF beta 2 was shown to bind sHer3 with a dissociation constant of 26 +/- 9 nM, while it showed a 1000-fold weaker binding to sHer2. Taken together, these results demonstrate that NDF is a high affinity ligand for Her3, but not for Hera. No increase in affinity of the NDF beta 2 for sHer3 was observed upon addition of sHer2 to the NDF beta 2-sHer3 mixture. Binding of NDF beta 2 to sHer3 did not induce receptor dimerization or oligomerization, the stoichiometry being one sHer3 per one NDF molecule. This finding suggests that transmembrane and/or intracellular domains of receptor family members or perhaps additional unidentified components may be involved in NDF induced dimerization and autophosphorylation, or alternatively, that dimerization is not the mechanism for Her3 autophosphorylation and signal transduction.
引用
收藏
页码:24604 / 24608
页数:5
相关论文
共 50 条
  • [31] Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4)
    Broughton, Marianne Nordlund
    Westgaard, Arne
    Paus, Elisabeth
    Oijordsbakken, Miriam
    Henanger, Karoline J.
    Naume, Bjorn
    Bjoro, Trine
    [J]. TUMOR BIOLOGY, 2017, 39 (06) : 1 - 11
  • [32] The role of the HER2 and HER3 in prostate cancer and their potential as therapeutic targets
    Rao, K.
    Gaughan, L.
    Robson, C.
    McCracken, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 61 : S177 - S177
  • [33] Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer
    Stahler, Arndt
    Heinemann, Volker
    Neumann, Jens
    Crispin, Alexander
    Schalhorn, Andreas
    Stintzing, Sebastian
    Giessen-Jung, Clemens
    von Weikersthal, Ludwig Fischer
    Vehling-Kaiser, Ursula
    Stauch, Martina
    Quietzsch, Detlef
    Holch, Julian W.
    Kruger, Stephan
    Haas, Michael
    Michl, Marlies
    von Einem, Jobst
    Kirchner, Thomas
    Jung, Andreas
    Modest, Dominik P.
    [J]. ANTI-CANCER DRUGS, 2017, 28 (07) : 717 - 722
  • [34] The involvement of EGFR, HER2 and HER3 in the basal cell carcinomas aggressiveness
    Florescu, Diana Elena
    Stepan, Alex Emilian
    Margaritescu, Claudiu
    Ciurea, Raluca Niculina
    Stepan, Mioara-Desdemona
    Simionescu, Cristiana Eugenia
    [J]. ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2018, 59 (02): : 479 - 484
  • [35] Serum HER2 extracellular domain before surgery compared with HER2 in breast cancer
    Zidan, J.
    Mzalbat, R.
    Sharabi, A.
    [J]. BREAST, 2015, 24 : S44 - S45
  • [36] In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer
    Spears, Melanie
    Taylor, Karen J.
    Munro, Alison F.
    Cunningham, Carrie A.
    Mallon, Elizabeth A.
    Twelves, Chris J.
    Cameron, David A.
    Thomas, Jeremy
    Bartlett, John M. S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (02) : 463 - 470
  • [37] Effects of HER2 and HER3 on EGFR trafficking and localization - a modelling study
    Resat, H
    Shankaran, H
    Wiley, H
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 13A - 13A
  • [38] Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab
    Todeschini, P.
    Cocco, E.
    Bellone, S.
    Varughese, J.
    Lin, K.
    Carrara, L.
    Guzzo, F.
    Buza, N.
    Hui, P.
    Silasi, D-A
    Ratner, E.
    Azodi, M.
    Schwartz, P. E.
    Rutherford, T. J.
    Pecorelli, S.
    Santin, A. D.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 105 (08) : 1176 - 1182
  • [39] Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab
    P Todeschini
    E Cocco
    S Bellone
    J Varughese
    K Lin
    L Carrara
    F Guzzo
    N Buza
    P Hui
    D-A Silasi
    E Ratner
    M Azodi
    P E Schwartz
    T J Rutherford
    S Pecorelli
    A D Santin
    [J]. British Journal of Cancer, 2011, 105 : 1176 - 1182
  • [40] The immunoexpression of EGFR, HER2 and HER3 in malignant serous ovarian tumors
    Cirstea, Andreea-Elena
    Stepan, Alex Emilian
    Margaritescu, Claudiu
    Zavoi, Roxana Eugenia
    Olimid, Daniel Alin
    Simionescu, Cristiana Eugenia
    [J]. ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2017, 58 (04): : 1269 - 1273